Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study

Ingrid Hokstad,Gia Deyab,Morten W. Fagerland,Torstein Lyberg,Gunnbjorg Hjeltnes,Øystein Førre,Stefan Agewall,Tom Eirik Mollnes,Ivana Hollan

Tumor necrosis factor inhibitors are associated with reduced complement activation in spondylarthropathies: An observational study

2019

Ingrid Hokstad
Gia Deyab
Morten W. Fagerland
Torstein Lyberg
Gunnbjorg Hjeltnes
Øystein Førre
Stefan Agewall
Tom Eirik Mollnes
Ivana Hollan

The Norwegian Women's Public Health Association The Norwegian Council on Cardiovascular Disease The Odd Fellow Foundation The Simon Fougner Hartmann Family Fund

Keywords:

Tumor necrosis factor alpha
Cancer research
Complement system
Medicine
Spondylarthropathies
Observational study
Psoriatic arthritis
Gastroenterology
TNF inhibitor
Internal medicine
Ankylosing spondylitis
Erythrocyte sedimentation rate
Methotrexate
Inflammation

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations